RT @ATRIUMRx: Despite improved therapies, many patients remain at significant CV risk. While we anxiously await the full results of REDUCE-…
RT @ATRIUMRx: Despite improved therapies, many patients remain at significant CV risk. While we anxiously await the full results of REDUCE-…
Despite improved therapies, many patients remain at significant CV risk. While we anxiously await the full results of REDUCE-IT, check out this comprehensive review by some of our colleagues on the role of TG in CVD and the existing evidence for omega-3s.
@UMBCardiology @UMmedschool
RT @mevans1114: Still processing the results of REDUCE-IT? @mmillermd1 and I foreshadowed the results and discussed hypertriglyceridemia as…
Still processing the results of REDUCE-IT? @mmillermd1 and I foreshadowed the results and discussed hypertriglyceridemia as an independent risk factor for coronary disease in July: https://t.co/v5GJIhg7RN @ATRIUMRx
RT @fralongva: Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia. #cvd #statins #ldl #triglycerides https://t.co/6NLiel…
Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia. #cvd #statins #ldl #triglycerides https://t.co/6NLielVoac https://t.co/PznFTO9Jba https://t.co/J9xrhIVZyA